Ascendis Pharma's supplemental application for SKYTROFA in adult GHD has been accepted by the FDA, aiming for broader patient access. Acceptance of the sBLA does not guarantee approval; the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback